Shalini Sharp, CFO & Executive Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 27,795 shares at $88.38 ($2.5M) on 2020-08-17, disclosed to the SEC on 2020-08-19.
Open-market sale of $2.5M RARE by CFO & Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.24 | 461 | $41K | 1.7% |
| 2 | $88.38 | 500 | $44K | 1.8% |
| 3 | $88.38 | 7,188 | $635K | 25.9% |
| 4 | $88.38 | 3,669 | $324K | 13.2% |
| 5 | $88.38 | 7,188 | $635K | 25.9% |
| 6 | $88.38 | 3,669 |
| $324K |
| 13.2% |
| 7 | $88.54 | 2,560 | $227K | 9.2% |
| 8 | $88.54 | 2,560 | $227K | 9.2% |
| Total | $88.41 avg | 27,795 | $2.5M | 100% |
| Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |
| RARE | SELL | 2019-04-17 | $133K | — | Filing → |